Skip to content
10-K

Annual Report

ALPINE IMMUNE SCIENCES, INC.

0001626199-24-000048

← back to feed
Filed
Mar 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 7, 2024 65.55M sh
Shares Diluted FY 2023 · Dec 31, 2023 50M sh
Shares Diluted FY 2023 · Dec 31, 2022 33.44M sh
Shares Diluted FY 2023 · Dec 31, 2021 25.48M sh
Capex FY 2023 · Dec 31, 2023 $487K
Capex FY 2023 · Dec 31, 2022 $412K
Capex FY 2023 · Dec 31, 2021 $118K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$79.01M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$43.75M
Operating Cash Flow FY 2023 · Dec 31, 2021 −$15.25M
Short Term Debt FY 2023 · Dec 31, 2023 $0
Short Term Debt FY 2023 · Dec 31, 2022 $3.38M
Cash And Equivalents FY 2023 · Dec 31, 2023 $43.92M
Cash And Equivalents FY 2023 · Dec 31, 2022 $13.38M
Stockholders Equity FY 2023 · Dec 31, 2023 $327.94M
Stockholders Equity FY 2023 · Dec 31, 2022 $179.42M
Stockholders Equity FY 2023 · Dec 31, 2021 $120.9M
Stockholders Equity FY 2023 · Dec 31, 2020 $62.16M
Current Liabilities FY 2023 · Dec 31, 2023 $41.98M
Current Liabilities FY 2023 · Dec 31, 2022 $58M
Total Liabilities FY 2023 · Dec 31, 2023 $51.91M
Total Liabilities FY 2023 · Dec 31, 2022 $107.27M
Current Assets FY 2023 · Dec 31, 2023 $330.03M
Current Assets FY 2023 · Dec 31, 2022 $240.99M
Total Assets FY 2023 · Dec 31, 2023 $379.85M
Total Assets FY 2023 · Dec 31, 2022 $286.69M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.64
Eps Diluted FY 2023 · Dec 31, 2022 −$1.73
Eps Diluted FY 2023 · Dec 31, 2021 −$1.98
Eps Basic FY 2023 · Dec 31, 2023 −$0.64
Eps Basic FY 2023 · Dec 31, 2022 −$1.73
Eps Basic FY 2023 · Dec 31, 2021 −$1.98
Sga Expense FY 2023 · Dec 31, 2023 $22.22M
Sga Expense FY 2023 · Dec 31, 2022 $17.97M
Sga Expense FY 2023 · Dec 31, 2021 $14.56M
Rd Expense FY 2023 · Dec 31, 2023 $80.9M
Rd Expense FY 2023 · Dec 31, 2022 $70.24M
Rd Expense FY 2023 · Dec 31, 2021 $58.74M
Net Income FY 2023 · Dec 31, 2023 −$32.18M
Net Income FY 2023 · Dec 31, 2022 −$57.76M
Net Income FY 2023 · Dec 31, 2021 −$50.33M
Operating Income FY 2023 · Dec 31, 2023 −$44.25M
Operating Income FY 2023 · Dec 31, 2022 −$58.15M
Operating Income FY 2023 · Dec 31, 2021 −$49.86M
Revenue FY 2023 · Dec 31, 2023 $58.88M
Revenue FY 2023 · Dec 31, 2022 $30.06M
Revenue FY 2023 · Dec 31, 2021 $23.44M